chr17_+_1182956
|
5.719
|
NM_172367
|
TUSC5
|
tumor suppressor candidate 5
|
chr22_+_23229959
|
5.354
|
NM_001178126
|
IGLL5
IGLC1
|
immunoglobulin lambda-like polypeptide 5
immunoglobulin lambda constant 1 (Mcg marker)
|
chrX_-_133119624
|
4.392
|
NM_001164617
NM_001164618
NM_001164619
NM_004484
|
GPC3
|
glypican 3
|
chrX_-_133119475
|
4.205
|
|
GPC3
|
glypican 3
|
chr17_+_59477169
|
3.883
|
NM_005994
|
TBX2
|
T-box 2
|
chr14_-_106791054
|
3.820
|
|
IGHV4-31
IGHV3-30
IGHA1
IGHD
IGHG1
IGHG2
IGHG3
IGHM
SCFV
|
immunoglobulin heavy variable 4-31
immunoglobulin heavy variable 3-30
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant delta
immunoglobulin heavy constant gamma 1 (G1m marker)
immunoglobulin heavy constant gamma 2 (G2m marker)
immunoglobulin heavy constant gamma 3 (G3m marker)
immunoglobulin heavy constant mu
single-chain Fv fragment
|
chr12_-_108991783
|
3.819
|
|
TMEM119
|
transmembrane protein 119
|
chr7_-_150038689
|
3.758
|
NM_002889
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
chr17_+_59477473
|
3.698
|
|
TBX2
|
T-box 2
|
chr14_-_107211131
|
3.549
|
|
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
chr14_-_107013122
|
3.235
|
|
IGHV4-31
IGHG1
|
immunoglobulin heavy variable 4-31
immunoglobulin heavy constant gamma 1 (G1m marker)
|
chr12_-_108991832
|
3.205
|
|
TMEM119
|
transmembrane protein 119
|
chr12_-_108991843
|
3.204
|
|
TMEM119
|
transmembrane protein 119
|
chr14_-_107099379
|
3.057
|
|
IGHG1
IGHG3
|
immunoglobulin heavy constant gamma 1 (G1m marker)
immunoglobulin heavy constant gamma 3 (G3m marker)
|
chr3_-_142607737
|
2.860
|
NM_013363
|
PCOLCE2
|
procollagen C-endopeptidase enhancer 2
|
chr2_+_85360373
|
2.842
|
NM_031283
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box)
|
chr17_+_59477710
|
2.790
|
|
TBX2
|
T-box 2
|
chr17_-_73511626
|
2.707
|
NM_020753
|
CASKIN2
|
CASK interacting protein 2
|
chr20_+_43344005
|
2.621
|
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
chr17_-_73511453
|
2.602
|
|
CASKIN2
|
CASK interacting protein 2
|
chr11_-_119211526
|
2.558
|
|
C1QTNF5
MFRP
|
C1q and tumor necrosis factor related protein 5
membrane frizzled-related protein
|
chr14_-_38725253
|
2.553
|
|
CLEC14A
|
C-type lectin domain family 14, member A
|
chr12_+_13044493
|
2.551
|
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A
|
chr1_+_47264669
|
2.548
|
NM_000779
NM_001099772
|
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1
|
chr9_+_139560243
|
2.547
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
chr4_+_4861371
|
2.522
|
NM_002448
|
MSX1
|
msh homeobox 1
|
chr14_-_107013474
|
2.509
|
|
IGHA1
IGHG1
|
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
|
chr11_-_2019070
|
2.501
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
chr9_+_139560193
|
2.473
|
NM_201446
|
EGFL7
|
EGF-like-domain, multiple 7
|
chr5_+_92920592
|
2.465
|
|
NR2F1
NR2F2
|
nuclear receptor subfamily 2, group F, member 1
nuclear receptor subfamily 2, group F, member 2
|
chr11_-_119211034
|
2.451
|
|
MFRP
|
membrane frizzled-related protein
|
chr12_-_108991893
|
2.413
|
NM_181724
|
TMEM119
|
transmembrane protein 119
|
chr1_+_22138757
|
2.321
|
NM_001013693
|
LDLRAD2
|
low density lipoprotein receptor class A domain containing 2
|
chr11_-_66084501
|
2.299
|
NM_020404
|
CD248
|
CD248 molecule, endosialin
|
chr16_+_31483066
|
2.291
|
NM_001042454
NM_001164719
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
chr20_+_43343523
|
2.277
|
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
chrX_-_132549421
|
2.270
|
|
GPC4
|
glypican 4
|
chr12_+_13043955
|
2.264
|
NM_003979
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A
|
chr19_-_1567875
|
2.215
|
NM_001174118
NM_203304
|
MEX3D
|
mex-3 homolog D (C. elegans)
|
chr12_+_13044352
|
2.211
|
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A
|
chr12_+_54393876
|
2.206
|
NM_006897
|
HOXC9
|
homeobox C9
|
chr14_+_96671015
|
2.201
|
NM_000623
|
BDKRB2
|
bradykinin receptor B2
|
chr11_-_57092283
|
2.172
|
NM_033396
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa
|
chr14_-_107113943
|
2.167
|
|
IGHA1
IGHG1
|
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
|
chr20_+_43343884
|
2.138
|
NM_003881
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
chr17_-_46667596
|
2.136
|
|
HOXB3
|
homeobox B3
|
chr1_-_16482426
|
2.130
|
NM_004431
|
EPHA2
|
EPH receptor A2
|
chr19_+_45312294
|
2.124
|
NM_001013257
NM_005581
|
BCAM
|
basal cell adhesion molecule (Lutheran blood group)
|
chr14_-_106725232
|
2.119
|
|
ZCWPW2
IGHV3-23
IGKV3-20
IGK@
|
zinc finger, CW type with PWWP domain 2
immunoglobulin heavy variable 3-23
immunoglobulin kappa variable 3-20
immunoglobulin kappa locus
|
chr11_-_2159784
|
2.118
|
|
IGF2
|
insulin-like growth factor 2 (somatomedin A)
|
chr11_-_61684981
|
2.095
|
NM_013401
|
RAB3IL1
|
RAB3A interacting protein (rabin3)-like 1
|
chr22_+_45898690
|
2.079
|
NM_001996
NM_006485
NM_006486
NM_006487
|
FBLN1
|
fibulin 1
|
chr17_+_41003360
|
2.060
|
|
|
|
chr12_+_54402795
|
2.035
|
NM_022658
|
HOXC8
|
homeobox C8
|
chr11_+_67810446
|
2.006
|
NM_006053
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
chr21_+_47401644
|
1.996
|
NM_001848
|
COL6A1
|
collagen, type VI, alpha 1
|
chr17_-_39675078
|
1.991
|
NM_002275
|
KRT15
|
keratin 15
|
chr19_-_4338750
|
1.990
|
NM_001013841
NM_017720
|
STAP2
|
signal transducing adaptor family member 2
|
chr13_+_113633625
|
1.988
|
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like
|
chrX_+_38420690
|
1.941
|
NM_004615
|
TSPAN7
|
tetraspanin 7
|
chr17_+_59533806
|
1.940
|
NM_018488
|
TBX4
|
T-box 4
|
chr1_+_154474694
|
1.922
|
NM_001098475
NM_182499
|
TDRD10
|
tudor domain containing 10
|
chr17_+_41003184
|
1.900
|
NM_003734
|
AOC3
|
amine oxidase, copper containing 3 (vascular adhesion protein 1)
|
chr4_-_55991746
|
1.890
|
NM_002253
|
KDR
|
kinase insert domain receptor (a type III receptor tyrosine kinase)
|
chr17_+_60704747
|
1.882
|
NM_006039
|
MRC2
|
mannose receptor, C type 2
|
chr14_-_52535765
|
1.851
|
|
NID2
|
nidogen 2 (osteonidogen)
|
chr5_+_170210711
|
1.811
|
NM_014211
|
GABRP
|
gamma-aminobutyric acid (GABA) A receptor, pi
|
chr14_-_106967080
|
1.808
|
|
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
chr3_+_32433342
|
1.796
|
|
CMTM7
|
CKLF-like MARVEL transmembrane domain containing 7
|
chr14_+_52118539
|
1.795
|
NM_152330
|
FRMD6
|
FERM domain containing 6
|
chr11_+_130029712
|
1.792
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
chr22_+_22385340
|
1.782
|
|
|
|
chr14_-_52535711
|
1.776
|
|
NID2
|
nidogen 2 (osteonidogen)
|
chr17_-_31242
|
1.771
|
|
|
|
chr17_+_74380676
|
1.765
|
NM_001142601
NM_021972
NM_182965
|
SPHK1
|
sphingosine kinase 1
|
chr10_-_125651494
|
1.755
|
NM_198148
|
CPXM2
|
carboxypeptidase X (M14 family), member 2
|
chr17_-_39684499
|
1.751
|
|
KRT19
|
keratin 19
|
chr5_+_32710742
|
1.749
|
NM_001204376
|
NPR3
|
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C)
|
chr19_-_11308184
|
1.740
|
NM_001136191
|
KANK2
|
KN motif and ankyrin repeat domains 2
|
chr7_-_140340575
|
1.728
|
|
DENND2A
|
DENN/MADD domain containing 2A
|
chr1_+_159175048
|
1.728
|
NM_001122951
|
DARC
|
Duffy blood group, chemokine receptor
|
chr1_-_38100575
|
1.724
|
NM_001038633
NM_001242908
NM_001242909
NM_001242910
|
RSPO1
|
R-spondin 1
|
chr14_+_96671163
|
1.701
|
|
BDKRB2
|
bradykinin receptor B2
|
chr17_-_46035109
|
1.700
|
NM_024320
|
PRR15L
|
proline rich 15-like
|
chr15_-_45422056
|
1.697
|
NM_144565
|
DUOXA1
|
dual oxidase maturation factor 1
|
chr11_+_65779461
|
1.692
|
NM_001323
|
CST6
|
cystatin E/M
|
chr11_+_75273100
|
1.687
|
NM_001207014
NM_001235
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
chr1_+_19970674
|
1.687
|
NM_005380
|
NBL1
|
neuroblastoma, suppression of tumorigenicity 1
|
chr11_+_75273245
|
1.682
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
chr5_-_115910406
|
1.680
|
NM_020796
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A
|
chr17_-_31386
|
1.671
|
NM_003585
|
DOC2B
|
double C2-like domains, beta
|
chr7_-_27183225
|
1.661
|
NM_019102
|
HOXA5
|
homeobox A5
|
chr17_+_635656
|
1.645
|
NM_024792
|
FAM57A
|
family with sequence similarity 57, member A
|
chr10_-_30316338
|
1.643
|
|
KIAA1462
|
KIAA1462
|
chr6_-_31550065
|
1.639
|
NM_002341
NM_009588
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
chr14_-_106586333
|
1.637
|
|
IGHV4-31
|
immunoglobulin heavy variable 4-31
|
chr18_+_7567313
|
1.636
|
NM_001105244
NM_002845
|
PTPRM
|
protein tyrosine phosphatase, receptor type, M
|
chr14_-_106174914
|
1.635
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
chr19_-_45737466
|
1.635
|
NM_138568
|
EXOC3L2
|
exocyst complex component 3-like 2
|
chr11_+_130029773
|
1.633
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
chr7_+_130131921
|
1.629
|
NM_002402
|
MEST
|
mesoderm specific transcript homolog (mouse)
|
chr16_-_66959418
|
1.618
|
NM_001128850
NM_004165
|
RRAD
|
Ras-related associated with diabetes
|
chr1_-_38100287
|
1.614
|
|
RSPO1
|
R-spondin 1
|
chr10_-_116164222
|
1.604
|
|
AFAP1L2
|
actin filament associated protein 1-like 2
|
chr22_+_23040394
|
1.592
|
|
IGL@
|
immunoglobulin lambda locus
|
chr20_-_62680880
|
1.582
|
NM_018419
|
SOX18
|
SRY (sex determining region Y)-box 18
|
chr14_-_52535737
|
1.579
|
|
NID2
|
nidogen 2 (osteonidogen)
|
chr11_-_100999793
|
1.564
|
NM_001202474
|
PGR
|
progesterone receptor
|
chr8_-_22550456
|
1.551
|
|
EGR3
|
early growth response 3
|
chr7_-_27192201
|
1.548
|
|
|
|
chr4_-_75719686
|
1.546
|
NM_001729
|
BTC
|
betacellulin
|
chr11_+_65082288
|
1.538
|
NM_006779
|
CDC42EP2
|
CDC42 effector protein (Rho GTPase binding) 2
|
chr12_+_52627007
|
1.533
|
|
KRT7
|
keratin 7
|
chr17_-_39743085
|
1.520
|
NM_000526
|
KRT14
|
keratin 14
|
chr2_+_42275017
|
1.510
|
NM_138370
|
PKDCC
|
protein kinase domain containing, cytoplasmic homolog (mouse)
|
chr15_-_40212425
|
1.505
|
|
GPR176
|
G protein-coupled receptor 176
|
chr14_-_105444693
|
1.480
|
NM_138420
|
AHNAK2
|
AHNAK nucleoprotein 2
|
chr14_+_24837225
|
1.473
|
NM_001198965
NM_004554
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
chr14_-_61115906
|
1.472
|
NM_005982
|
SIX1
|
SIX homeobox 1
|
chr19_+_41725098
|
1.467
|
NM_001699
NM_021913
|
AXL
|
AXL receptor tyrosine kinase
|
chr14_+_24838301
|
1.463
|
NM_001198966
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
chr19_-_43969723
|
1.454
|
NM_014400
|
LYPD3
|
LY6/PLAUR domain containing 3
|
chr3_+_32433151
|
1.452
|
NM_138410
NM_181472
|
CMTM7
|
CKLF-like MARVEL transmembrane domain containing 7
|
chr17_-_34079896
|
1.448
|
NM_139285
|
GAS2L2
|
growth arrest-specific 2 like 2
|
chr19_+_41725259
|
1.447
|
|
AXL
|
AXL receptor tyrosine kinase
|
chr1_-_95392501
|
1.447
|
NM_001839
|
CNN3
|
calponin 3, acidic
|
chr1_-_161993586
|
1.437
|
NM_015441
|
OLFML2B
|
olfactomedin-like 2B
|
chr13_-_36705513
|
1.435
|
NM_004734
|
DCLK1
|
doublecortin-like kinase 1
|
chr12_+_53491448
|
1.435
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
chr11_-_61658853
|
1.433
|
NM_021727
|
FADS3
|
fatty acid desaturase 3
|
chr3_-_120169493
|
1.431
|
NM_007085
|
FSTL1
|
follistatin-like 1
|
chr5_+_131593388
|
1.424
|
|
PDLIM4
|
PDZ and LIM domain 4
|
chr14_-_106725620
|
1.421
|
|
IGHV4-31
IGHV3-23
IGHA1
IGHG1
IGHM
|
immunoglobulin heavy variable 4-31
immunoglobulin heavy variable 3-23
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
immunoglobulin heavy constant mu
|
chr2_+_71162995
|
1.420
|
NM_001692
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1
|
chr1_-_33366838
|
1.417
|
NM_033504
|
TMEM54
|
transmembrane protein 54
|
chr11_+_12399024
|
1.409
|
NM_018222
|
PARVA
|
parvin, alpha
|
chr11_-_2019007
|
1.403
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
chr11_+_2159910
|
1.399
|
|
|
|
chr14_-_106471439
|
1.392
|
|
IGHA1
IGHG1
IGHM
|
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
immunoglobulin heavy constant mu
|
chr19_+_41725277
|
1.377
|
|
AXL
|
AXL receptor tyrosine kinase
|
chr22_-_36424397
|
1.362
|
NM_001082578
NM_001082579
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2
|
chr5_+_146614525
|
1.359
|
NM_001112724
NM_145001
|
STK32A
|
serine/threonine kinase 32A
|
chr19_+_45349560
|
1.356
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
chr7_+_94023872
|
1.355
|
NM_000089
|
COL1A2
|
collagen, type I, alpha 2
|
chr19_+_41725135
|
1.350
|
|
AXL
|
AXL receptor tyrosine kinase
|
chr12_+_53491417
|
1.344
|
NM_002178
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
chr17_+_4402128
|
1.340
|
NM_001124758
|
SPNS2
|
spinster homolog 2 (Drosophila)
|
chr14_-_106641585
|
1.335
|
|
IGHV4-31
IGHA1
IGHA2
IGHG1
|
immunoglobulin heavy variable 4-31
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant alpha 2 (A2m marker)
immunoglobulin heavy constant gamma 1 (G1m marker)
|
chr16_+_68771214
|
1.335
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
chr11_+_289113
|
1.325
|
NM_025092
|
ATHL1
|
ATH1, acid trehalase-like 1 (yeast)
|
chr5_+_76506705
|
1.319
|
NM_001029851
NM_001029852
NM_001029853
NM_001029854
NM_003719
|
PDE8B
|
phosphodiesterase 8B
|
chr5_-_108063960
|
1.317
|
|
HP07349
|
uncharacterized protein HP07349
|
chr5_+_63461652
|
1.317
|
NM_001113561
NM_178532
|
RNF180
|
ring finger protein 180
|
chr13_+_111137249
|
1.315
|
|
COL4A2
|
collagen, type IV, alpha 2
|
chr5_+_40909617
|
1.313
|
|
C7
|
complement component 7
|
chr9_-_130331350
|
1.312
|
NM_022833
|
FAM129B
|
family with sequence similarity 129, member B
|
chr22_+_31478845
|
1.307
|
NM_001207017
|
SMTN
|
smoothelin
|
chr18_+_29078026
|
1.294
|
NM_001943
|
DSG2
|
desmoglein 2
|
chr19_+_41725131
|
1.277
|
|
AXL
|
AXL receptor tyrosine kinase
|
chr15_+_81071708
|
1.276
|
NM_018689
|
KIAA1199
|
KIAA1199
|
chr2_-_20424627
|
1.276
|
NM_002997
|
SDC1
|
syndecan 1
|
chr11_+_47608229
|
1.267
|
NM_001164379
|
FAM180B
|
family with sequence similarity 180, member B
|
chr16_-_85145995
|
1.262
|
NM_198491
|
FAM92B
|
family with sequence similarity 92, member B
|
chr10_-_128077011
|
1.261
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
chr14_-_106518424
|
1.255
|
|
IGH@
IGHA1
IGHG1
IGHG2
IGHM
|
immunoglobulin heavy locus
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant gamma 1 (G1m marker)
immunoglobulin heavy constant gamma 2 (G2m marker)
immunoglobulin heavy constant mu
|
chr11_-_2159925
|
1.248
|
|
IGF2
|
insulin-like growth factor 2 (somatomedin A)
|
chr1_-_228135587
|
1.245
|
NM_003395
|
WNT9A
|
wingless-type MMTV integration site family, member 9A
|
chr12_-_118541655
|
1.241
|
NM_019086
|
VSIG10
|
V-set and immunoglobulin domain containing 10
|
chr5_+_40909558
|
1.237
|
NM_000587
|
C7
|
complement component 7
|
chr10_-_128077072
|
1.235
|
NM_003474
NM_021641
|
ADAM12
|
ADAM metallopeptidase domain 12
|
chr10_+_112836784
|
1.229
|
NM_000681
|
ADRA2A
|
adrenergic, alpha-2A-, receptor
|
chrX_+_128872924
|
1.220
|
NM_003399
|
XPNPEP2
|
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound
|
chr11_+_61276271
|
1.217
|
NM_001145077
|
LRRC10B
|
leucine rich repeat containing 10B
|
chr9_+_124461365
|
1.217
|
|
DAB2IP
|
DAB2 interacting protein
|
chr5_+_131593331
|
1.212
|
NM_001131027
NM_003687
|
PDLIM4
|
PDZ and LIM domain 4
|
chr7_+_127881330
|
1.212
|
NM_000230
|
LEP
|
leptin
|
chr14_-_107131217
|
1.210
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
chr12_-_29936685
|
1.207
|
NM_001193451
|
TMTC1
|
transmembrane and tetratricopeptide repeat containing 1
|
chr4_-_122744782
|
1.204
|
|
CCNA2
|
cyclin A2
|
chr16_+_31484497
|
1.203
|
NM_015927
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
chr2_+_47596447
|
1.199
|
|
EPCAM
|
epithelial cell adhesion molecule
|
chr6_+_31783530
|
1.190
|
|
HSPA1A
HSPA1B
|
heat shock 70kDa protein 1A
heat shock 70kDa protein 1B
|
chr2_+_121103670
|
1.181
|
NM_002193
|
INHBB
|
inhibin, beta B
|
chr12_-_53575121
|
1.180
|
|
CSAD
|
cysteine sulfinic acid decarboxylase
|
chr19_+_45349392
|
1.178
|
NM_001042724
NM_002856
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
chr19_+_45349584
|
1.177
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
chr17_+_60705051
|
1.169
|
|
MRC2
|
mannose receptor, C type 2
|
chr19_+_15218141
|
1.169
|
NM_033025
|
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans)
|
chr11_+_43963809
|
1.165
|
NM_001145033
|
C11orf96
|
chromosome 11 open reading frame 96
|
chr15_-_40212227
|
1.161
|
|
|
|
chr9_+_137533643
|
1.158
|
NM_000093
|
COL5A1
|
collagen, type V, alpha 1
|
chr4_-_39529099
|
1.157
|
NM_001184700
NM_001184701
NM_003359
|
UGDH
|
UDP-glucose 6-dehydrogenase
|
chr14_-_24804243
|
1.155
|
NM_001198568
NM_001198592
NM_139247
|
ADCY4
|
adenylate cyclase 4
|
chr6_+_150285109
|
1.154
|
NM_025218
|
ULBP1
|
UL16 binding protein 1
|
chr3_+_9944511
|
1.149
|
NM_001193380
NM_153480
|
IL17RE
|
interleukin 17 receptor E
|
chr11_+_130029699
|
1.142
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
chr19_+_751108
|
1.139
|
NM_173481
|
C19orf21
|
chromosome 19 open reading frame 21
|
chr14_-_69445978
|
1.137
|
|
ACTN1
|
actinin, alpha 1
|
chr17_-_31204187
|
1.136
|
|
MYO1D
|
myosin ID
|
chr2_+_48757292
|
1.135
|
NM_001198595
NM_006873
|
STON1
|
stonin 1
|